NCT00051025View on ClinicalTrials.gov

Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

January 31, 2001

Study Completion Date

September 30, 2006

Conditions
Non-Hodgkin's LymphomaLymphoma, B-cellLymphoma, Low-grade
Interventions
DRUG

ONTAK

Trial Locations (2)

40503

Central Baptist Hospital, Lexington

70006

Hematology and Oncology Services, Metairie

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00051025 - Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL) | Biotech Hunter | Biotech Hunter